BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gonzalez A, Huerta-Salgado C, Orozco-Aguilar J, Aguirre F, Tacchi F, Simon F, Cabello-Verrugio C. Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD). Oxid Med Cell Longev 2020;2020:1617805. [PMID: 33149804 DOI: 10.1155/2020/1617805] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Arora M, Kutinová Canová N, Farghali H. mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174857] [Reference Citation Analysis]
2 Castillo-Castro C, Martagón-Rosado AJ, Ortiz-Lopez R, Garrido-Treviño LF, Villegas-Albo M, Bosques-Padilla FJ. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. World J Hepatol 2021; 13(11): 1494-1511 [PMID: 34904026 DOI: 10.4254/wjh.v13.i11.1494] [Reference Citation Analysis]
3 Skrzypczak D, Skrzypczak-Zielińska M, Ratajczak AE, Szymczak-Tomczak A, Eder P, Słomski R, Dobrowolska A, Krela-Kaźmierczak I. Myostatin and Follistatin-New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications. Biomedicines 2021;9:1301. [PMID: 34680417 DOI: 10.3390/biomedicines9101301] [Reference Citation Analysis]
4 Sharma A, Anand SK, Singh N, Dwarkanath A, Dwivedi UN, Kakkar P. Berbamine induced activation of the SIRT1/LKB1/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats. Food Funct 2021;12:892-909. [PMID: 33411880 DOI: 10.1039/d0fo02501a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zhai M, Yan X, Liu J, Long Z, Zhao S, Li W, Liu Y, Hai C. Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice. Diabetes Metab Syndr Obes 2021;14:1035-42. [PMID: 33727836 DOI: 10.2147/DMSO.S294020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Orozco-Aguilar J, Simon F, Cabello-Verrugio C. Redox-Dependent Effects in the Physiopathological Role of Bile Acids. Oxid Med Cell Longev 2021;2021:4847941. [PMID: 34527174 DOI: 10.1155/2021/4847941] [Reference Citation Analysis]
7 Kwon HC, Sohn H, Kim DH, Jeong CH, Kim DW, Han SG. Effects of Flutriafol Fungicide on the Lipid Accumulation in Human Liver Cells and Rat Liver. Foods 2021;10:1346. [PMID: 34200939 DOI: 10.3390/foods10061346] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Fan M, Choi YJ, Tang Y, Kim JH, Kim BG, Lee B, Bae SM, Kim EK. AGL9: A Novel Hepatoprotective Peptide from the Larvae of Edible Insects Alleviates Obesity-Induced Hepatic Inflammation by Regulating AMPK/Nrf2 Signaling. Foods 2021;10:1973. [PMID: 34574082 DOI: 10.3390/foods10091973] [Reference Citation Analysis]
9 Chen S, Che S, Li S, Ruan Z. The combined impact of decabromodiphenyl ether and high fat exposure on non-alcoholic fatty liver disease in vivo and in vitro. Toxicology 2021;464:153015. [PMID: 34757160 DOI: 10.1016/j.tox.2021.153015] [Reference Citation Analysis]
10 Cheng B, Zhou AZ, Ge W, Yao XM, Wang J. Mechanism of Huo-Xue-Qu-Yu Formula in Treating Nonalcoholic Hepatic Steatosis by Regulating Lipid Metabolism and Oxidative Stress in Rats. Evid Based Complement Alternat Med 2021;2021:6026319. [PMID: 34007294 DOI: 10.1155/2021/6026319] [Reference Citation Analysis]
11 Dong XC, Chowdhury K, Huang M, Kim HG. Signal Transduction and Molecular Regulation in Fatty Liver Disease. Antioxid Redox Signal 2021. [PMID: 33906425 DOI: 10.1089/ars.2021.0076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yang XD, Chen Z, Ye L, Chen J, Yang YY. Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-κB p65 pathway. Pharm Biol 2021;59:922-32. [PMID: 34243681 DOI: 10.1080/13880209.2021.1945112] [Reference Citation Analysis]
13 Li N, Liu Y, Yu S, Hu B, Zhao H. Composite BMI and Waist-to-Height Ratio Index for Risk Assessment of Non-alcoholic Fatty Liver Disease in Adult Populations. Hepat Mon 2021;20. [DOI: 10.5812/hepatmon.103607] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yu H, Ren Y, Wei H, Xing W, Xu G, Li T, Xue M, Luo L. Dietary oxidized fish oil negatively affected the feed utilization, health status and fillet quality of juvenile Amur sturgeon, A. schrenckii. Aquaculture 2022;546:737290. [DOI: 10.1016/j.aquaculture.2021.737290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Du T, Fang Q, Zhang Z, Zhu C, Xu R, Chen G, Wang Y. Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPARα Pathway. Metabolites 2022;12:55. [PMID: 35050176 DOI: 10.3390/metabo12010055] [Reference Citation Analysis]
16 Zhang Y, Wen J, Liu D, Qiu Z, Zhu Q, Li R, Zhang Y. Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice. Life Sci 2021;281:119778. [PMID: 34192596 DOI: 10.1016/j.lfs.2021.119778] [Reference Citation Analysis]